Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Science
Neurology
Other Science
Biotechnology
Research
Pharmaceutical
Health
Clinical Trials
Chiesi Global Rare Diseases Awards Research Grants

More Like This

PR Newswire associated0

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies

PR Newswire associated0

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients

Oxford-Harrington Rare Disease Centre Opens 2025 Call for Proposals

PR Newswire associated0

Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.

PA Media Assignments associated0

“One Month to Save Lives”: Families race against 1st August deadline to secure access to life-saving rare disease drug